Mark Canney

2.1k total citations · 1 hit paper
58 papers, 1.2k citations indexed

About

Mark Canney is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Canney has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Nephrology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Canney's work include Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (13 papers) and Dialysis and Renal Disease Management (13 papers). Mark Canney is often cited by papers focused on Renal Diseases and Glomerulopathies (14 papers), Chronic Kidney Disease and Diabetes (13 papers) and Dialysis and Renal Disease Management (13 papers). Mark Canney collaborates with scholars based in Canada, Ireland and United States. Mark Canney's co-authors include Dearbhla Kelly, Michael Clarkson, Conall M. O’Seaghdha, Yvonne Williams, Patrick O’Kelly, Peter J. Conlon, Mark A. Little, Sean J. Barbour, Rose Anne Kenny and Matthew O’Connell and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Kidney International.

In The Last Decade

Mark Canney

55 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Posterior Reversible Encephalopathy Syndrome in End-Stage Kidney Disease: Not Strictly Posterior or Reversible

2015 437 citations Mark Canney, Dearbhla Kelly et al. American Journal of Nephrology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Canney Canada	16	446	304	285	270	193	58	1.2k
Ryszard Gellert Poland	14	70 0.2×	158 0.5×	501 1.8×	81 0.3×	374 1.9×	48	1.7k
Joanie Chung United States	15	105 0.2×	202 0.7×	1.8k 6.2×	255 0.9×	634 3.3×	35	2.8k
Victória Zeghbi Cochenski Borba Brazil	22	76 0.2×	143 0.5×	113 0.4×	118 0.4×	215 1.1×	66	1.5k
Jutta Gellermann Germany	22	49 0.1×	106 0.3×	770 2.7×	234 0.9×	229 1.2×	40	1.6k
R. S. C. Rodger United Kingdom	22	190 0.4×	50 0.2×	486 1.7×	140 0.5×	592 3.1×	70	1.8k
Arema A. Pereira United States	10	79 0.2×	76 0.3×	519 1.8×	49 0.2×	151 0.8×	12	1.1k
Serhan Tuğlular Türkiye	17	46 0.1×	148 0.5×	300 1.1×	63 0.2×	123 0.6×	96	986
Yuri Battaglia Italy	16	62 0.1×	97 0.3×	635 2.2×	85 0.3×	133 0.7×	69	1.0k
Mislav Radić Croatia	17	69 0.2×	204 0.7×	129 0.5×	31 0.1×	219 1.1×	102	1.1k
Halil Zeki Tonbul Türkiye	18	149 0.3×	55 0.2×	461 1.6×	101 0.4×	119 0.6×	50	1.2k

Countries citing papers authored by Mark Canney

Since Specialization

Citations

This map shows the geographic impact of Mark Canney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Canney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Canney more than expected).

Fields of papers citing papers by Mark Canney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Canney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Canney. The network helps show where Mark Canney may publish in the future.

Co-authorship network of co-authors of Mark Canney

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Canney. A scholar is included among the top collaborators of Mark Canney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Canney. Mark Canney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Massicotte‐Azarniouch, David, Mark Canney, Peter A. Merkel, et al.. (2024). Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians. Kidney Medicine. 6(8). 100858–100858. 2 indexed citations

Holmes, Daniel T., Mark Canney, Ognjenka Djurdjev, et al.. (2024). Assessing Discharge Communication and Follow-up of Acute Kidney Injury in British Columbia: A Retrospective Chart Review. Canadian Journal of Kidney Health and Disease. 11. 1035177264–1035177264. 2 indexed citations

Han, Jialin, Yinshan Zhao, Mark Canney, et al.. (2023). Are patients with primary glomerular disease at increased risk of malignancy?. Nephrology Dialysis Transplantation. 39(6). 910–919. 3 indexed citations

Canney, Mark, et al.. (2023). Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study. American Journal of Kidney Diseases. 82(6). 725–736. 2 indexed citations

Massicotte‐Azarniouch, David, Mark Canney, Manish M. Sood, & Gregory L. Hundemer. (2023). Managing Hyperkalemia in the Modern Era: A Case-Based Approach. Kidney International Reports. 8(7). 1290–1300. 3 indexed citations

Hussain, Junayd, Mark Canney, Edward G. Clark, et al.. (2023). Impaired Renal Function and Major Cardiovascular Events in Young Adults. Journal of the American College of Cardiology. 82(13). 1316–1327. 11 indexed citations

Wang, Tzu‐Fei, Nicholas Grubic, Marc Carrier, et al.. (2023). Risk of venous thromboembolism or hemorrhage among individuals with chronic kidney disease on prophylactic anticoagulant after hip or knee arthroplasty. American Journal of Hematology. 98(9). 1374–1382. 5 indexed citations

Massicotte‐Azarniouch, David, et al.. (2022). The value of repeat kidney biopsy during an atypical course of membranous nephropathy. BMC Nephrology. 23(1). 240–240. 2 indexed citations

Hundemer, Gregory L., Navdeep Tangri, Manish M. Sood, et al.. (2021). The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD. Kidney International Reports. 6(12). 2993–3001. 16 indexed citations

10.

Clark, Edward G., Lauralyn McIntyre, Irene Watpool, et al.. (2021). Intravenous albumin for the prevention of hemodynamic instability during sustained low-efficiency dialysis: a randomized controlled feasibility trial (The SAFER-SLED Study). Annals of Intensive Care. 11(1). 174–174. 3 indexed citations

11.

Hill, Kevin, Ewa Sucha, Emily Rhodes, et al.. (2021). Amiodarone, Verapamil, or Diltiazem Use With Direct Oral Anticoagulants and the Risk of Hemorrhage in Older Adults. CJC Open. 4(3). 315–323. 16 indexed citations

12.

Levin, Adeera, et al.. (2020). A Provincial Survey of the Contemporary Management of Autosomal Dominant Polycystic Kidney Disease. Canadian Journal of Kidney Health and Disease. 7. 2248827462–2248827462. 2 indexed citations

13.

Canney, Mark, et al.. (2019). Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, Canada. Kidney International. 96(2). 421–428. 18 indexed citations

14.

Canney, Mark, Siobhán Leahy, Siobhán Scarlett, et al.. (2018). Kidney Disease in Women is Associated with Disadvantaged Childhood Socioeconomic Position. American Journal of Nephrology. 47(5). 292–299. 5 indexed citations

15.

Canney, Mark, Donal J. Sexton, Matthew O’Connell, et al.. (2017). Kidney Function Estimated From Cystatin C, But Not Creatinine, Is Related to Objective Tests of Physical Performance in Community-Dwelling Older Adults. The Journals of Gerontology Series A. 72(11). 1554–1560. 11 indexed citations

16.

Canney, Mark, Matthew O’Connell, Catríona Murphy, et al.. (2016). Single Agent Antihypertensive Therapy and Orthostatic Blood Pressure Behaviour in Older Adults Using Beat-to-Beat Measurements: The Irish Longitudinal Study on Ageing. PLoS ONE. 11(1). e0146156–e0146156. 45 indexed citations

17.

Canney, Mark, Paul O’Hara, Caitríona M. McEvoy, et al.. (2016). Spatial and Temporal Clustering of Anti-Glomerular Basement Membrane Disease. Clinical Journal of the American Society of Nephrology. 11(8). 1392–1399. 67 indexed citations

18.

Canney, Mark, Dearbhla Kelly, & Michael Clarkson. (2015). Posterior Reversible Encephalopathy Syndrome in End-Stage Kidney Disease: Not Strictly Posterior or Reversible. American Journal of Nephrology. 41(3). 177–182. 437 indexed citations breakdown →

19.

O’Regan, John, Mark Canney, Dervla M. Connaughton, et al.. (2015). Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. Journal of Nephrology. 29(2). 269–276. 54 indexed citations

20.

O’Neill, Michael J., et al.. (1996). The novel σ ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil. Neurochemistry International. 28(2). 193–207. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact